nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—SLC22A1—Estropipate—osteoporosis	0.236	0.307	CbGbCtD
Latanoprost—SLCO2B1—Conjugated Estrogens—osteoporosis	0.23	0.301	CbGbCtD
Latanoprost—SLCO2B1—Estradiol—osteoporosis	0.202	0.264	CbGbCtD
Latanoprost—SLC22A1—Estradiol—osteoporosis	0.0978	0.128	CbGbCtD
Latanoprost—Stinging—Calcium Acetate—osteoporosis	0.00363	0.0155	CcSEcCtD
Latanoprost—Uveitis—Pamidronate—osteoporosis	0.00359	0.0153	CcSEcCtD
Latanoprost—Iritis—Risedronate—osteoporosis	0.00347	0.0148	CcSEcCtD
Latanoprost—Exacerbation of asthma—Estradiol—osteoporosis	0.00338	0.0144	CcSEcCtD
Latanoprost—Iritis—Pamidronate—osteoporosis	0.0033	0.0141	CcSEcCtD
Latanoprost—Uveitis—Zoledronate—osteoporosis	0.00328	0.014	CcSEcCtD
Latanoprost—Iritis—Zoledronate—osteoporosis	0.00301	0.0129	CcSEcCtD
Latanoprost—Embolism—Estropipate—osteoporosis	0.0026	0.0111	CcSEcCtD
Latanoprost—Embolism—Raloxifene—osteoporosis	0.00252	0.0108	CcSEcCtD
Latanoprost—Dermatitis atopic—Ibandronate—osteoporosis	0.00216	0.00924	CcSEcCtD
Latanoprost—Embolism—Ethinyl Estradiol—osteoporosis	0.00211	0.009	CcSEcCtD
Latanoprost—Dermatitis atopic—Risedronate—osteoporosis	0.00178	0.00761	CcSEcCtD
Latanoprost—Eyelid oedema—Estradiol—osteoporosis	0.00175	0.00747	CcSEcCtD
Latanoprost—Inflammation—Estropipate—osteoporosis	0.00172	0.00735	CcSEcCtD
Latanoprost—Embolism—Conjugated Estrogens—osteoporosis	0.00172	0.00734	CcSEcCtD
Latanoprost—Inflammation—Ibandronate—osteoporosis	0.00165	0.00705	CcSEcCtD
Latanoprost—Photophobia—Calcitriol—osteoporosis	0.00147	0.00628	CcSEcCtD
Latanoprost—Blepharitis—Estradiol—osteoporosis	0.00143	0.00613	CcSEcCtD
Latanoprost—Hepatic function abnormal—Estropipate—osteoporosis	0.00139	0.00592	CcSEcCtD
Latanoprost—Embolism—Estradiol—osteoporosis	0.00137	0.00587	CcSEcCtD
Latanoprost—Inflammation—Risedronate—osteoporosis	0.00136	0.00581	CcSEcCtD
Latanoprost—Inflammation—Pamidronate—osteoporosis	0.00129	0.00552	CcSEcCtD
Latanoprost—Dry eye—Risedronate—osteoporosis	0.00122	0.0052	CcSEcCtD
Latanoprost—Asthma—Etidronic acid—osteoporosis	0.00121	0.00517	CcSEcCtD
Latanoprost—Inflammation—Zoledronate—osteoporosis	0.00118	0.00504	CcSEcCtD
Latanoprost—Inflammation—Conjugated Estrogens—osteoporosis	0.00114	0.00486	CcSEcCtD
Latanoprost—Eczema—Ethinyl Estradiol—osteoporosis	0.00109	0.00467	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Alendronate—osteoporosis	0.00107	0.00459	CcSEcCtD
Latanoprost—Oedema—Calcium Acetate—osteoporosis	0.00105	0.00448	CcSEcCtD
Latanoprost—Asthma—Estropipate—osteoporosis	0.00105	0.00447	CcSEcCtD
Latanoprost—Hepatic function abnormal—Pamidronate—osteoporosis	0.00104	0.00445	CcSEcCtD
Latanoprost—Eye irritation—Estradiol—osteoporosis	0.00103	0.00442	CcSEcCtD
Latanoprost—Asthma—Alendronate—osteoporosis	0.00103	0.00441	CcSEcCtD
Latanoprost—Asthma—Ibandronate—osteoporosis	0.001	0.00429	CcSEcCtD
Latanoprost—Bronchitis—Raloxifene—osteoporosis	0.000975	0.00417	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Estropipate—osteoporosis	0.000973	0.00416	CcSEcCtD
Latanoprost—Bronchitis—Ibandronate—osteoporosis	0.000965	0.00412	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Ibandronate—osteoporosis	0.000933	0.00399	CcSEcCtD
Latanoprost—Eye pain—Zoledronate—osteoporosis	0.00092	0.00393	CcSEcCtD
Latanoprost—Hepatic function abnormal—Conjugated Estrogens—osteoporosis	0.000916	0.00391	CcSEcCtD
Latanoprost—Inflammation—Estradiol—osteoporosis	0.00091	0.00389	CcSEcCtD
Latanoprost—Pain—Calcium Acetate—osteoporosis	0.000896	0.00383	CcSEcCtD
Latanoprost—Urinary tract infection—Raloxifene—osteoporosis	0.000879	0.00375	CcSEcCtD
Latanoprost—Conjunctivitis—Raloxifene—osteoporosis	0.000879	0.00375	CcSEcCtD
Latanoprost—Urinary tract infection—Ibandronate—osteoporosis	0.00087	0.00372	CcSEcCtD
Latanoprost—Urinary tract infection—Calcitriol—osteoporosis	0.000852	0.00364	CcSEcCtD
Latanoprost—Conjunctivitis—Calcitriol—osteoporosis	0.000852	0.00364	CcSEcCtD
Latanoprost—Erythema—Etidronic acid—osteoporosis	0.000843	0.0036	CcSEcCtD
Latanoprost—Asthma—Risedronate—osteoporosis	0.000827	0.00353	CcSEcCtD
Latanoprost—Bronchitis—Ethinyl Estradiol—osteoporosis	0.000816	0.00349	CcSEcCtD
Latanoprost—Dry eye—Estradiol—osteoporosis	0.000815	0.00348	CcSEcCtD
Latanoprost—Angina pectoris—Risedronate—osteoporosis	0.000806	0.00344	CcSEcCtD
Latanoprost—Connective tissue disorder—Raloxifene—osteoporosis	0.000797	0.00341	CcSEcCtD
Latanoprost—Bronchitis—Risedronate—osteoporosis	0.000795	0.0034	CcSEcCtD
Latanoprost—Pain—Ergocalciferol—osteoporosis	0.000792	0.00338	CcSEcCtD
Latanoprost—Connective tissue disorder—Ibandronate—osteoporosis	0.000789	0.00337	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Ethinyl Estradiol—osteoporosis	0.000788	0.00337	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Risedronate—osteoporosis	0.000769	0.00329	CcSEcCtD
Latanoprost—Mediastinal disorder—Estropipate—osteoporosis	0.000755	0.00323	CcSEcCtD
Latanoprost—Pruritus—Calcium Acetate—osteoporosis	0.000741	0.00317	CcSEcCtD
Latanoprost—Urinary tract infection—Ethinyl Estradiol—osteoporosis	0.000735	0.00314	CcSEcCtD
Latanoprost—Hepatic function abnormal—Estradiol—osteoporosis	0.000733	0.00313	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Pamidronate—osteoporosis	0.000731	0.00312	CcSEcCtD
Latanoprost—Erythema—Estropipate—osteoporosis	0.000729	0.00312	CcSEcCtD
Latanoprost—Mediastinal disorder—Ibandronate—osteoporosis	0.000724	0.00309	CcSEcCtD
Latanoprost—Erythema—Alendronate—osteoporosis	0.000718	0.00307	CcSEcCtD
Latanoprost—Asthma—Zoledronate—osteoporosis	0.000718	0.00307	CcSEcCtD
Latanoprost—Arthralgia—Etidronic acid—osteoporosis	0.000718	0.00307	CcSEcCtD
Latanoprost—Urinary tract infection—Risedronate—osteoporosis	0.000717	0.00306	CcSEcCtD
Latanoprost—Conjunctivitis—Risedronate—osteoporosis	0.000717	0.00306	CcSEcCtD
Latanoprost—Eczema—Estradiol—osteoporosis	0.000713	0.00305	CcSEcCtD
Latanoprost—Discomfort—Etidronic acid—osteoporosis	0.000709	0.00303	CcSEcCtD
Latanoprost—Back pain—Estropipate—osteoporosis	0.000705	0.00301	CcSEcCtD
Latanoprost—Erythema—Ibandronate—osteoporosis	0.000699	0.00299	CcSEcCtD
Latanoprost—Dizziness—Calcium Acetate—osteoporosis	0.000693	0.00296	CcSEcCtD
Latanoprost—Asthma—Conjugated Estrogens—osteoporosis	0.000692	0.00296	CcSEcCtD
Latanoprost—Erythema—Calcitriol—osteoporosis	0.000685	0.00293	CcSEcCtD
Latanoprost—Conjunctivitis—Pamidronate—osteoporosis	0.000681	0.00291	CcSEcCtD
Latanoprost—Urinary tract infection—Pamidronate—osteoporosis	0.000681	0.00291	CcSEcCtD
Latanoprost—Back pain—Ibandronate—osteoporosis	0.000676	0.00289	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Zoledronate—osteoporosis	0.000668	0.00285	CcSEcCtD
Latanoprost—Connective tissue disorder—Ethinyl Estradiol—osteoporosis	0.000667	0.00285	CcSEcCtD
Latanoprost—Bronchitis—Conjugated Estrogens—osteoporosis	0.000665	0.00284	CcSEcCtD
Latanoprost—Connective tissue disorder—Risedronate—osteoporosis	0.000651	0.00278	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Conjugated Estrogens—osteoporosis	0.000643	0.00275	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.000627	0.00268	CcSEcCtD
Latanoprost—Conjunctivitis—Zoledronate—osteoporosis	0.000622	0.00266	CcSEcCtD
Latanoprost—Urinary tract infection—Zoledronate—osteoporosis	0.000622	0.00266	CcSEcCtD
Latanoprost—Arthralgia—Estropipate—osteoporosis	0.000621	0.00265	CcSEcCtD
Latanoprost—Connective tissue disorder—Pamidronate—osteoporosis	0.000618	0.00264	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.000617	0.00263	CcSEcCtD
Latanoprost—Chest pain—Alendronate—osteoporosis	0.000612	0.00261	CcSEcCtD
Latanoprost—Discomfort—Alendronate—osteoporosis	0.000604	0.00258	CcSEcCtD
Latanoprost—Arthralgia—Raloxifene—osteoporosis	0.000601	0.00257	CcSEcCtD
Latanoprost—Chest pain—Raloxifene—osteoporosis	0.000601	0.00257	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.000597	0.00255	CcSEcCtD
Latanoprost—Mediastinal disorder—Risedronate—osteoporosis	0.000597	0.00255	CcSEcCtD
Latanoprost—Chest pain—Ibandronate—osteoporosis	0.000595	0.00254	CcSEcCtD
Latanoprost—Arthralgia—Ibandronate—osteoporosis	0.000595	0.00254	CcSEcCtD
Latanoprost—Oedema—Estropipate—osteoporosis	0.000595	0.00254	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000591	0.00253	CcSEcCtD
Latanoprost—Discomfort—Ibandronate—osteoporosis	0.000588	0.00251	CcSEcCtD
Latanoprost—Nervous system disorder—Estropipate—osteoporosis	0.000584	0.00249	CcSEcCtD
Latanoprost—Chest pain—Calcitriol—osteoporosis	0.000583	0.00249	CcSEcCtD
Latanoprost—Skin disorder—Estropipate—osteoporosis	0.000578	0.00247	CcSEcCtD
Latanoprost—Discomfort—Calcitriol—osteoporosis	0.000576	0.00246	CcSEcCtD
Latanoprost—Back pain—Ethinyl Estradiol—osteoporosis	0.000572	0.00244	CcSEcCtD
Latanoprost—Mediastinal disorder—Pamidronate—osteoporosis	0.000567	0.00242	CcSEcCtD
Latanoprost—Nervous system disorder—Raloxifene—osteoporosis	0.000565	0.00242	CcSEcCtD
Latanoprost—Connective tissue disorder—Zoledronate—osteoporosis	0.000565	0.00241	CcSEcCtD
Latanoprost—Skin disorder—Raloxifene—osteoporosis	0.00056	0.00239	CcSEcCtD
Latanoprost—Nervous system disorder—Ibandronate—osteoporosis	0.00056	0.00239	CcSEcCtD
Latanoprost—Back pain—Risedronate—osteoporosis	0.000557	0.00238	CcSEcCtD
Latanoprost—Skin disorder—Ibandronate—osteoporosis	0.000554	0.00237	CcSEcCtD
Latanoprost—Asthma—Estradiol—osteoporosis	0.000553	0.00237	CcSEcCtD
Latanoprost—Erythema—Pamidronate—osteoporosis	0.000548	0.00234	CcSEcCtD
Latanoprost—Skin disorder—Calcitriol—osteoporosis	0.000543	0.00232	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000542	0.00232	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000534	0.00228	CcSEcCtD
Latanoprost—Bronchitis—Estradiol—osteoporosis	0.000532	0.00227	CcSEcCtD
Latanoprost—Back pain—Pamidronate—osteoporosis	0.00053	0.00226	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000525	0.00224	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.00052	0.00222	CcSEcCtD
Latanoprost—Mediastinal disorder—Zoledronate—osteoporosis	0.000518	0.00221	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Estradiol—osteoporosis	0.000514	0.0022	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000509	0.00218	CcSEcCtD
Latanoprost—Pain—Estropipate—osteoporosis	0.000509	0.00218	CcSEcCtD
Latanoprost—Pain—Alendronate—osteoporosis	0.000501	0.00214	CcSEcCtD
Latanoprost—Erythema—Zoledronate—osteoporosis	0.0005	0.00214	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.0005	0.00214	CcSEcCtD
Latanoprost—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000499	0.00213	CcSEcCtD
Latanoprost—Discomfort—Ethinyl Estradiol—osteoporosis	0.000497	0.00212	CcSEcCtD
Latanoprost—Pain—Raloxifene—osteoporosis	0.000493	0.00211	CcSEcCtD
Latanoprost—Arthralgia—Risedronate—osteoporosis	0.000491	0.0021	CcSEcCtD
Latanoprost—Chest pain—Risedronate—osteoporosis	0.000491	0.0021	CcSEcCtD
Latanoprost—Pain—Ibandronate—osteoporosis	0.000488	0.00209	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000487	0.00208	CcSEcCtD
Latanoprost—Pruritus—Etidronic acid—osteoporosis	0.000487	0.00208	CcSEcCtD
Latanoprost—Back pain—Zoledronate—osteoporosis	0.000484	0.00207	CcSEcCtD
Latanoprost—Oedema—Ethinyl Estradiol—osteoporosis	0.000482	0.00206	CcSEcCtD
Latanoprost—Erythema—Conjugated Estrogens—osteoporosis	0.000482	0.00206	CcSEcCtD
Latanoprost—Conjunctivitis—Estradiol—osteoporosis	0.00048	0.00205	CcSEcCtD
Latanoprost—Urinary tract infection—Estradiol—osteoporosis	0.00048	0.00205	CcSEcCtD
Latanoprost—Pain—Calcitriol—osteoporosis	0.000478	0.00204	CcSEcCtD
Latanoprost—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000473	0.00202	CcSEcCtD
Latanoprost—Vision blurred—Zoledronate—osteoporosis	0.000472	0.00202	CcSEcCtD
Latanoprost—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000469	0.002	CcSEcCtD
Latanoprost—Arthralgia—Pamidronate—osteoporosis	0.000466	0.00199	CcSEcCtD
Latanoprost—Back pain—Conjugated Estrogens—osteoporosis	0.000466	0.00199	CcSEcCtD
Latanoprost—Nervous system disorder—Risedronate—osteoporosis	0.000461	0.00197	CcSEcCtD
Latanoprost—Discomfort—Pamidronate—osteoporosis	0.000461	0.00197	CcSEcCtD
Latanoprost—Skin disorder—Risedronate—osteoporosis	0.000457	0.00195	CcSEcCtD
Latanoprost—Vision blurred—Conjugated Estrogens—osteoporosis	0.000454	0.00194	CcSEcCtD
Latanoprost—Oedema—Pamidronate—osteoporosis	0.000447	0.00191	CcSEcCtD
Latanoprost—Nervous system disorder—Pamidronate—osteoporosis	0.000439	0.00187	CcSEcCtD
Latanoprost—Connective tissue disorder—Estradiol—osteoporosis	0.000435	0.00186	CcSEcCtD
Latanoprost—Rash—Etidronic acid—osteoporosis	0.000434	0.00185	CcSEcCtD
Latanoprost—Dermatitis—Etidronic acid—osteoporosis	0.000433	0.00185	CcSEcCtD
Latanoprost—Headache—Etidronic acid—osteoporosis	0.000431	0.00184	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000429	0.00183	CcSEcCtD
Latanoprost—Chest pain—Zoledronate—osteoporosis	0.000426	0.00182	CcSEcCtD
Latanoprost—Arthralgia—Zoledronate—osteoporosis	0.000426	0.00182	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000423	0.00181	CcSEcCtD
Latanoprost—Pruritus—Estropipate—osteoporosis	0.000421	0.0018	CcSEcCtD
Latanoprost—Discomfort—Zoledronate—osteoporosis	0.000421	0.0018	CcSEcCtD
Latanoprost—Dyspnoea—Risedronate—osteoporosis	0.000419	0.00179	CcSEcCtD
Latanoprost—Pruritus—Alendronate—osteoporosis	0.000415	0.00177	CcSEcCtD
Latanoprost—Arthralgia—Conjugated Estrogens—osteoporosis	0.00041	0.00175	CcSEcCtD
Latanoprost—Chest pain—Conjugated Estrogens—osteoporosis	0.00041	0.00175	CcSEcCtD
Latanoprost—Oedema—Zoledronate—osteoporosis	0.000408	0.00175	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000407	0.00174	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000407	0.00174	CcSEcCtD
Latanoprost—Pruritus—Ibandronate—osteoporosis	0.000404	0.00173	CcSEcCtD
Latanoprost—Pain—Risedronate—osteoporosis	0.000402	0.00172	CcSEcCtD
Latanoprost—Nervous system disorder—Zoledronate—osteoporosis	0.000401	0.00171	CcSEcCtD
Latanoprost—Mediastinal disorder—Estradiol—osteoporosis	0.000399	0.00171	CcSEcCtD
Latanoprost—Dyspnoea—Pamidronate—osteoporosis	0.000399	0.0017	CcSEcCtD
Latanoprost—Skin disorder—Zoledronate—osteoporosis	0.000397	0.0017	CcSEcCtD
Latanoprost—Pruritus—Calcitriol—osteoporosis	0.000395	0.00169	CcSEcCtD
Latanoprost—Dizziness—Estropipate—osteoporosis	0.000394	0.00168	CcSEcCtD
Latanoprost—Oedema—Conjugated Estrogens—osteoporosis	0.000393	0.00168	CcSEcCtD
Latanoprost—Dizziness—Alendronate—osteoporosis	0.000388	0.00166	CcSEcCtD
Latanoprost—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000386	0.00165	CcSEcCtD
Latanoprost—Erythema—Estradiol—osteoporosis	0.000386	0.00165	CcSEcCtD
Latanoprost—Pain—Pamidronate—osteoporosis	0.000382	0.00163	CcSEcCtD
Latanoprost—Skin disorder—Conjugated Estrogens—osteoporosis	0.000382	0.00163	CcSEcCtD
Latanoprost—Dizziness—Raloxifene—osteoporosis	0.000381	0.00163	CcSEcCtD
Latanoprost—Dizziness—Ibandronate—osteoporosis	0.000377	0.00161	CcSEcCtD
Latanoprost—Rash—Estropipate—osteoporosis	0.000375	0.0016	CcSEcCtD
Latanoprost—Dermatitis—Estropipate—osteoporosis	0.000375	0.0016	CcSEcCtD
Latanoprost—Back pain—Estradiol—osteoporosis	0.000373	0.00159	CcSEcCtD
Latanoprost—Headache—Estropipate—osteoporosis	0.000373	0.00159	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000372	0.00159	CcSEcCtD
Latanoprost—Rash—Alendronate—osteoporosis	0.00037	0.00158	CcSEcCtD
Latanoprost—Dermatitis—Alendronate—osteoporosis	0.000369	0.00158	CcSEcCtD
Latanoprost—Headache—Alendronate—osteoporosis	0.000367	0.00157	CcSEcCtD
Latanoprost—Dyspnoea—Zoledronate—osteoporosis	0.000364	0.00156	CcSEcCtD
Latanoprost—Rash—Raloxifene—osteoporosis	0.000364	0.00155	CcSEcCtD
Latanoprost—Dermatitis—Raloxifene—osteoporosis	0.000363	0.00155	CcSEcCtD
Latanoprost—Headache—Raloxifene—osteoporosis	0.000361	0.00154	CcSEcCtD
Latanoprost—Rash—Ibandronate—osteoporosis	0.00036	0.00154	CcSEcCtD
Latanoprost—Dermatitis—Ibandronate—osteoporosis	0.00036	0.00154	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000358	0.00153	CcSEcCtD
Latanoprost—Headache—Ibandronate—osteoporosis	0.000358	0.00153	CcSEcCtD
Latanoprost—Rash—Calcitriol—osteoporosis	0.000352	0.00151	CcSEcCtD
Latanoprost—Dermatitis—Calcitriol—osteoporosis	0.000352	0.0015	CcSEcCtD
Latanoprost—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000351	0.0015	CcSEcCtD
Latanoprost—Headache—Calcitriol—osteoporosis	0.00035	0.0015	CcSEcCtD
Latanoprost—Pain—Zoledronate—osteoporosis	0.000349	0.00149	CcSEcCtD
Latanoprost—Pruritus—Ethinyl Estradiol—osteoporosis	0.000341	0.00146	CcSEcCtD
Latanoprost—Pain—Conjugated Estrogens—osteoporosis	0.000336	0.00144	CcSEcCtD
Latanoprost—Pruritus—Risedronate—osteoporosis	0.000333	0.00142	CcSEcCtD
Latanoprost—Arthralgia—Estradiol—osteoporosis	0.000328	0.0014	CcSEcCtD
Latanoprost—Chest pain—Estradiol—osteoporosis	0.000328	0.0014	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000326	0.00139	CcSEcCtD
Latanoprost—Discomfort—Estradiol—osteoporosis	0.000324	0.00139	CcSEcCtD
Latanoprost—Dizziness—Ethinyl Estradiol—osteoporosis	0.000319	0.00136	CcSEcCtD
Latanoprost—Pruritus—Pamidronate—osteoporosis	0.000316	0.00135	CcSEcCtD
Latanoprost—Oedema—Estradiol—osteoporosis	0.000315	0.00135	CcSEcCtD
Latanoprost—Dizziness—Risedronate—osteoporosis	0.000311	0.00133	CcSEcCtD
Latanoprost—Nervous system disorder—Estradiol—osteoporosis	0.000309	0.00132	CcSEcCtD
Latanoprost—Skin disorder—Estradiol—osteoporosis	0.000306	0.00131	CcSEcCtD
Latanoprost—Rash—Ethinyl Estradiol—osteoporosis	0.000304	0.0013	CcSEcCtD
Latanoprost—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000304	0.0013	CcSEcCtD
Latanoprost—Headache—Ethinyl Estradiol—osteoporosis	0.000302	0.00129	CcSEcCtD
Latanoprost—Rash—Risedronate—osteoporosis	0.000297	0.00127	CcSEcCtD
Latanoprost—Dermatitis—Risedronate—osteoporosis	0.000296	0.00127	CcSEcCtD
Latanoprost—Dizziness—Pamidronate—osteoporosis	0.000296	0.00126	CcSEcCtD
Latanoprost—Headache—Risedronate—osteoporosis	0.000295	0.00126	CcSEcCtD
Latanoprost—Pruritus—Zoledronate—osteoporosis	0.000289	0.00123	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000287	0.00123	CcSEcCtD
Latanoprost—Rash—Pamidronate—osteoporosis	0.000282	0.0012	CcSEcCtD
Latanoprost—Dermatitis—Pamidronate—osteoporosis	0.000282	0.0012	CcSEcCtD
Latanoprost—Dyspnoea—Estradiol—osteoporosis	0.000281	0.0012	CcSEcCtD
Latanoprost—Headache—Pamidronate—osteoporosis	0.00028	0.0012	CcSEcCtD
Latanoprost—Pruritus—Conjugated Estrogens—osteoporosis	0.000278	0.00119	CcSEcCtD
Latanoprost—Dizziness—Zoledronate—osteoporosis	0.00027	0.00115	CcSEcCtD
Latanoprost—Pain—Estradiol—osteoporosis	0.000269	0.00115	CcSEcCtD
Latanoprost—Dizziness—Conjugated Estrogens—osteoporosis	0.00026	0.00111	CcSEcCtD
Latanoprost—Rash—Zoledronate—osteoporosis	0.000258	0.0011	CcSEcCtD
Latanoprost—Dermatitis—Zoledronate—osteoporosis	0.000257	0.0011	CcSEcCtD
Latanoprost—Headache—Zoledronate—osteoporosis	0.000256	0.00109	CcSEcCtD
Latanoprost—Rash—Conjugated Estrogens—osteoporosis	0.000248	0.00106	CcSEcCtD
Latanoprost—Dermatitis—Conjugated Estrogens—osteoporosis	0.000248	0.00106	CcSEcCtD
Latanoprost—Headache—Conjugated Estrogens—osteoporosis	0.000246	0.00105	CcSEcCtD
Latanoprost—Pruritus—Estradiol—osteoporosis	0.000223	0.000952	CcSEcCtD
Latanoprost—Dizziness—Estradiol—osteoporosis	0.000208	0.000889	CcSEcCtD
Latanoprost—Rash—Estradiol—osteoporosis	0.000198	0.000848	CcSEcCtD
Latanoprost—Dermatitis—Estradiol—osteoporosis	0.000198	0.000847	CcSEcCtD
Latanoprost—Headache—Estradiol—osteoporosis	0.000197	0.000843	CcSEcCtD
